Company News: Page (1) of 1 - 12/26/17 Email this story to a friend. email article Print this page (Article printing at page facebook

Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion

-- Immediately accretive transaction includes development and commercial assets including AMITIZAŽ (lubiprostone), a leading product in branded constipation market ---- Mallinckrodt expects accretion ... (December 26, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Manufacturing,Sales,Distribution,Manufacturing/Production,Marketing,Insurance,Manufacturing,Sales & Marketing,Health Care,Internet,Business Issues,Administration,Traffic Analysis/Reporting,Law & Regulations,Management,Finance/Accounting,Sales,Finance/Accounting,Sales,Pro AV,Post/Production,Management,Presentors,Management,Business,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved